Bioimics is a Swedish biotechnology company focusing on development of novel antibacterial compounds, ribozyme inhibitors, for the treatment of Healthcare Associated Infections.
Looking for a particular Bioimics AB employee's phone or email?
The Bioimics AB annual revenue was $1 million in 2026.
Bioimics AB is based in Uppsala, Uppsala.
The NAICS codes for Bioimics AB are [5417, 54, 541713, 54171, 541].
The SIC codes for Bioimics AB are [873, 87].